Paul M. Ridker

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Inflammation and Atherosclerosis

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men

Progress and challenges in translating the biology of atherosclerosis

Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

From Vulnerable Plaque to Vulnerable Patient

Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention

Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men

Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease

C-Reactive Protein Levels and Outcomes after Statin Therapy

C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events

From Vulnerable Plaque to Vulnerable Patient

Inflammation in Atherosclerosis

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk

A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women

Interpretation of the evidence for the efficacy and safety of statin therapy

Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women

Efficient Bayesian mixed-model analysis increases association power in large cohorts

Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes

Effect of Statin Therapy on C-Reactive Protein Levels

Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women

Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in Women

Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events

Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease

Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein

High-Sensitivity C-Reactive Protein

Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

Inflammation as a Cardiovascular Risk Factor

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men

Effect of sleep loss on C-Reactive protein, an inflammatory marker of cardiovascular risk

Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer

Blood Levels of Long-Chain n–3 Fatty Acids and the Risk of Sudden Death

Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality

Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men

C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

Physical Activity and Reduced Risk of Cardiovascular Events

Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk

Plasma Concentration of C-Reactive Protein and Risk of Developing Peripheral Vascular Disease

From C-Reactive Protein to Interleukin-6 to Interleukin-1

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

Elevation of Tumor Necrosis Factor-α and Increased Risk of Recurrent Coronary Events After Myocardial Infarction

Prevention Conference V

Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms

Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction

A guiding map for inflammation

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism

Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials

Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

Low-Dose Aspirin in the Primary Prevention of Cancer

Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

Novel Clinical Markers of Vascular Wall Inflammation

Non–HDL Cholesterol, Apolipoproteins A-I and B₁₀₀, Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women

A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism

Blood Pressure and Inflammation in Apparently Healthy Men

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials

Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials

Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine

Inflammatory Biomarkers, Hormone Replacement Therapy, and Incident Coronary Heart Disease

Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease

IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial

Ethnic Distribution of Factor V Leiden in 4047 Men and Women

Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?

Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

Population Analysis of Large Copy Number Variants and Hotspots of Human Genetic Disease

Clinical Efficacy of an Automated High-Sensitivity C-Reactive Protein Assay

C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk

A Multivariate Genome-Wide Association Analysis of 10 LDL Subfractions, and Their Response to Statin Treatment, in 1868 Caucasians

Sugar-Sweetened Beverages and Genetic Risk of Obesity

Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials

Stroke genetics informs drug discovery and risk prediction across ancestries

Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women

Inflammation and atherosclerosis: role of C-Reactive protein in risk assessment

Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

Soluble P-Selectin and the Risk of Future Cardiovascular Events

Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)

Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials

Inflammation, Immunity, and Infection in Atherothrombosis

Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen

Prospective Study of C-Reactive Protein, Homocysteine, and Plasma Lipid Levels as Predictors of Sudden Cardiac Death

Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease

High-Sensitivity C-Reactive Protein: A Novel and Promising Marker of Coronary Heart Disease

Clinical Usefulness of Very High and Very Low Levels of C-Reactive Protein Across the Full Range of Framingham Risk Scores

The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women

The Long- and Short-Term Impact of Elevated Body Mass Index on the Risk of New Atrial Fibrillation

Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women

Statins: new American guidelines for prevention of cardiovascular disease

Interrelationships Among Circulating Interleukin-6, C-Reactive Protein, and Traditional Cardiovascular Risk Factors in Women

High-sensitivity C-reactive proteinClinical importance

Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures

Soluble CD40L and Cardiovascular Risk in Women

The Primary Prevention of Myocardial Infarction

Cystatin C deficiency in human atherosclerosis and aortic aneurysms

C-Reactive Protein

Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular Risk

Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events

Hormone Replacement Therapy and Increased Plasma Concentration of C-Reactive Protein

Dietary Calcium, Vitamin D, and the Prevalence of Metabolic Syndrome in Middle-Aged and Older U.S. Women

Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis

Genome-wide association study reveals three susceptibility loci for common migraine in the general population

Targeting cardiovascular inflammation: next steps in clinical translation

Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events

Rosuvastatin in the Primary Prevention of Cardiovascular Disease Among Patients With Low Levels of Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein

Rapid Reduction in C-Reactive Protein With Cerivastatin Among 785 Patients With Primary Hypercholesterolemia

Serum Amyloid A as a Predictor of Coronary Artery Disease and Cardiovascular Outcome in Women

Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in Women

Absence of Diurnal Variation of C-Reactive Protein Concentrations in Healthy Human Subjects

Variability and Classification Accuracy of Serial High-Sensitivity C-Reactive Protein Measurements in Healthy Adults

A Test in Context

Association of Physical Activity and Body Mass Index With Novel and Traditional Cardiovascular Biomarkers in Women

Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function.

Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

Relation between markers of systemic vascular inflammation and smoking in women

Prognostic Significance of the Centers for Disease Control/American Heart Association High-Sensitivity C-Reactive Protein Cut Points for Cardiovascular and Other Outcomes in Patients With Stable Coronary Artery Disease

Genome-wide association studies identify loci associated with age at menarche and age at natural menopause

Novel Inflammatory Markers of Coronary Risk

C-reactive protein and other inflammatory risk markers in acute coronary syndromes

Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis

Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab

<i>TET2</i>-Driven Clonal Hematopoiesis and Response to Canakinumab

The neutrophil–lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials

COVID-19 – A vascular disease

Forty-Three Loci Associated with Plasma Lipoprotein Size, Concentration, and Cholesterol Content in Genome-Wide Analysis

Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men

Loci Related to Metabolic-Syndrome Pathways Including LEPR,HNF1A, IL6R, and GCKR Associate with Plasma C-Reactive Protein: The Women's Genome Health Study

PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis

Novel Association of ABO Histo-Blood Group Antigen with Soluble ICAM-1: Results of a Genome-Wide Association Study of 6,578 Women

Interrelation of Hyperhomocyst(e)inemia, Factor V Leiden, and Risk of Future Venous Thromboembolism

Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism

Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events

Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease

Alcohol Consumption and Plasma Concentration of C-Reactive Protein

Blood Pressure, C-Reactive Protein, and Risk of Future Cardiovascular Events

C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients

Evaluating Novel Cardiovascular Risk Factors: Can We Better Predict Heart Attacks?

Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes

Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or Dyslipidemia

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study

Association of Moderate Alcohol Consumption and Plasma Concentration of Endogenous Tissue-Type Plasminogen Activator

Magnesium Intake, C-Reactive Protein, and the Prevalence of Metabolic Syndrome in Middle-Aged and Older U.S. Women

Prospective study of endogenous tissue plasminogen activator and risk of stroke

Fried food consumption, genetic risk, and body mass index: gene-diet interaction analysis in three US cohort studies

Reported Outcomes in Major Cardiovascular Clinical Trials Funded by For-Profit and Not-for-Profit Organizations: 2000-2005

Periodontal disease and risk of subsequent cardiovascular disease in U.S. male physicians

Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction

High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit

Risk Factors for Progression of Peripheral Arterial Disease in Large and Small Vessels

Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin

Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians.

Exercise reduces inflammatory cell production and cardiovascular inflammation via instruction of hematopoietic progenitor cells

LDL cholesterol: controversies and future therapeutic directions

Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease

Genome-wide association analysis identifies TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucoma

Inflammation, C‐Reactive Protein, and Atherothrombosis

Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)

Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score

Sex Hormone Levels and Risk of Cardiovascular Events in Postmenopausal Women

Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy

Inflammatory Biomarkers and Risks of Myocardial Infarction, Stroke, Diabetes, and Total Mortality: Implications for Longevity

Relationship of total and abdominal adiposity with CRP and IL-6 in women

Rosuvastatin for Primary Prevention in Older Persons With Elevated C-Reactive Protein and Low to Average Low-Density Lipoprotein Cholesterol Levels: Exploratory Analysis of a Randomized Trial

Effects of Ramipril on Plasma Fibrinolytic Balance in Patients With Acute Anterior Myocardial Infarction

Anticytokine Agents

<i>The American Journal of Cardiology</i> and <i>Journal of Periodontology</i> Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease

Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19

Comparison of the Framingham and Reynolds Risk Scores for Global Cardiovascular Risk Prediction in the Multiethnic Women's Health Initiative

Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score

Impact of Traditional and Novel Risk Factors on the Relationship Between Socioeconomic Status and Incident Cardiovascular Events

Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study

Aspirin triggers antiinflammatory 15-epi-lipoxin A ₄ and inhibits thromboxane in a randomized human trial

Circulating Cell Adhesion Molecules Are Correlated With Ultrasound-Based Assessment of Carotid Atherosclerosis

C-Reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study)

High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention

G20210A Mutation in Prothrombin Gene and Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in a Large Cohort of US Men

Lipid levels and the risk of ischemic stroke in women

Antioxidant Vitamins C and E Improve Endothelial Function in Children With Hyperlipidemia

Discordance of Low-Density Lipoprotein (LDL) Cholesterol With Alternative LDL-Related Measures and Future Coronary Events

HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial

Factor V Leiden and Risks of Recurrent Idiopathic Venous Thromboembolism

Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials

A Novel Protein Glycan Biomarker and Future Cardiovascular Disease Events

Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men.

High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy

Lipoprotein(a) and Risk of Type 2 Diabetes

Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations

On the Use of Variance per Genotype as a Tool to Identify Quantitative Trait Interaction Effects: A Report from the Women's Genome Health Study

Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism

Relative Efficacy of Atorvastatin 80 mg and Pravastatin 40 mg in Achieving the Dual Goals of Low-Density Lipoprotein Cholesterol &lt;70 mg/dl and C-Reactive Protein &lt;2 mg/l

Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women

A statin-dependent QTL for GATM expression is associated with statin-induced myopathy

Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial

Genome-wide Association Analysis of Blood-Pressure Traits in African-Ancestry Individuals Reveals Common Associated Genes in African and Non-African Populations

Cardiovascular Event Reduction and Adverse Events Among Subjects Attaining Low-Density Lipoprotein Cholesterol &lt;50 mg/dl With Rosuvastatin

Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis

Soluble Intercellular Adhesion Molecule-1, Soluble Vascular Adhesion Molecule-1, and the Development of Symptomatic Peripheral Arterial Disease in Men

Efficacy of Rosuvastatin Among Men and Women With Moderate Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive Protein

Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy

Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events

Statin Use and Leg Functioning in Patients With and Without Lower-Extremity Peripheral Arterial Disease

Adverse Effects of Low-Dose Methotrexate

Association of Common <i>CRP</i> Gene Variants with CRP Levels and Cardiovascular Events

Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents

Circulating Branched-Chain Amino Acids and Incident Cardiovascular Disease in a Prospective Cohort of US Women

Prospective Study of <i>Chlamydia pneumoniae</i> IgG Seropositivity and Risks of Future Myocardial Infarction

Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)—Can C-Reactive Protein Be Used to Target Statin Therapy in Primary Prevention?

Lipoprotein(a), Measured With an Assay Independent of Apolipoprotein(a) Isoform Size, and Risk of Future Cardiovascular Events Among Initially Healthy Women

C-Reactive Protein Is Independently Associated With Fasting Insulin in Nondiabetic Women

C-REACTIVE PROTEIN, INFLAMMATION, AND CORONARY RISK

C-reactive protein comes of age

Cost Effectiveness of Thrombolytic Therapy with Streptokinase in Elderly Patients with Suspected Acute Myocardial Infarction

A prospective evaluation of lipoprotein-associated phospholipase A2levels and the risk of future cardiovascular events in women

Targeting innate immunity-driven inflammation in CKD and cardiovascular disease

Early Versus Delayed Angiotensin-Converting Enzyme Inhibition Therapy in Acute Myocardial Infarction

Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis

C-Reactive Protein: Eighty Years from Discovery to Emergence as a Major Risk Marker for Cardiovascular Disease

The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease††Published simultaneously in the Journal of Periodontology, the Official Journal of the American Academy of Periodontology.

Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease

Blood pressure and risk of developing type 2 diabetes mellitus: The Women's Health Study

Arterial and Venous Thrombosis Is Not Associated With the 4G/5G Polymorphism in the Promoter of the Plasminogen Activator Inhibitor Gene in a Large Cohort of US Men

Lipoprotein Particle Size and Concentration by Nuclear Magnetic Resonance and Incident Type 2 Diabetes in Women

Height and incidence of cardiovascular disease in male physicians.

Population Distributions of C-reactive Protein in Apparently Healthy Men and Women in the United States: Implication for Clinical Interpretation

Inflammation and Atherothrombosis

Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial

Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes

Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive protein

Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes

Polymorphism in the <i>CETP</i> Gene Region, HDL Cholesterol, and Risk of Future Myocardial Infarction

Hemoglobin A1c Predicts Diabetes but Not Cardiovascular Disease in Nondiabetic Women

Proposed Cardiovascular Risk Assessment Algorithm Using High-Sensitivity C-Reactive Protein and Lipid Screening

Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients

Polymorphisms of the HNF1A Gene Encoding Hepatocyte Nuclear Factor-1α are Associated with C-Reactive Protein

Novel locus including FGF21 is associated with dietary macronutrient intake

Prospective Study of Herpes Simplex Virus, Cytomegalovirus, and the Risk of Future Myocardial Infarction and Stroke

Physical and neurobehavioral determinants of reproductive onset and success

C-reactive protein, inflammation, and coronary risk

Hepatic Venocclusive Disease Associated With the Consumption of Pyrrolizidine Containing Dietary Supplements